Applied BioCode Licenses Patents to Molecular Devices | GenomeWeb

NEW YORK (GenomeWeb) – Applied BioCode said today that it has signed a license and supply agreement for its barcoded magnetic bead (BMB) technology with bioanalytics firm Molecular Devices.

The deal gives Molecular Devices access to specific Applied BioCode BMB patents for use on its own microplate reading devices within the life sciences, food and beverage research, and environmental testing markets. Further details of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.